- Global Pharma News & Resources

Weekly Life Science News Round Up: 18th – 22nd April

A round-up of the latest news from the Life Science industry; including Clinical Research, Drug Development, Cell and Gene Therapy and more news from 18th – 22nd April.

Hikma completes acquisition of Custopharm

Hikma Pharmaceuticals announces that it has completed its acquisition of Custopharm Inc. from Water Street Healthcare Partners (‘Water Street’).

Panthera Biopartners raises £10 million to accelerate its dedicated clinical trial site expansion across the UK and Western Europe

Panthera Biosciences has secured £10 million of investment from BGF and Gresham House Ventures, the latter investing on behalf of the Baronsmead VCTs.

Evaluate announces global strategic collaboration with Treehill Partners

Evaluate and Treehill Partners announces that they have entered into a global strategic collaboration to combine Evaluate’s industry leading data analytics and strategic consulting with Treehill’s world class transaction advisory and execution services in healthcare.

Thermo Fisher Scientific opens bioprocessing manufacturing site in Ogden, Utah

Thermo Fisher Scientific celebrates the opening of its new single-use technology manufacturing site in Ogden, Utah.

Tackling health disparities and inequities for women and heart failure: new program encourages black and Latina women to demand more from their care

Boehringer Ingelheim and Eli Lilly and Company announces the launch of Hear Your Heart, a health initiative that empowers women with heart failure to prioritise their care.

PacBio and Children’s Mercy Kansas City expand collaboration taking a multi-omics approach to characterise rare disease

PacBio announces an expanded research collaboration with Children’s Mercy Kansas City to use the multi-omics capabilities of PacBio’s Sequel IIe system in the study of genetic disease.

DNDi and BenevolentAI collaborate to accelerate life-saving drug discovery research in dengue

BenevolentAI and Drugs for Neglected Disease initiative (DNDi) announces they have begun a joint research project to tackle dengue, one of the world’s most prevalent infectious diseases.

X-Chem’s new AI-powered ecosystem to accelerate drug discovery

X-Chem today announces the availability of XD3 – X-Chem’s Dynamic Drug Discovery ecosystem for biopharma partners and clients.

Labcorp enhances cell and gene therapy development support through collaboration with Xcell Biosciences

Labcorp is collaborating with Xcell Biosciences to advance critical work that helps clients effectively bring innovative cell and gene therapies to market.

Kite receives U.S. FDA approval of new state-of-the-art CAR T-cell therapy manufacturing facility in Maryland

Kite, a Gilead company, announces the U.S. Food and Drug Administration (FDA) has approved commercial production at the company’s new CAR T-cell therapy manufacturing facility in Frederick, Maryland.

Bora Pharmaceuticals to expand operations with $10m+ investment

Fast-growing contract development and manufacturing organisation (CDMO) BORA Pharmaceuticals, has announced a planned investment of $10 million to expand its Oral Solid Dose capabilities across facilities in Zhuhan, Taiwan and Mississauga, Ontario.

BioXcel Therapeutics announces formation of OnkosXcel Therapeutics to develop medicines focused in oncology

BioXcel Therapeutics announces the formation of wholly-owned subsidiary OnkosXcel Therapeutics to develop transformative medicines in oncology.

EVERSANA and UpScriptHealth announce integrated, direct-to-patient platform, transforming the patient journey to accelerate therapy access, affordability, and adherence

EVERSANA announces a strategic partnership to create a direct-to-patient platform that will transform the patient experience to help accelerate access to therapies worldwide.

Advanced Clinical continues global expansion into Europe with new office in Switzerland

Advanced Clinical announces its continued expansion into Europe with the opening of a new office in Zug, Switzerland.

Moderna and Thermo Fisher Scientific honored for COVID-19 vaccine efforts

The PPD clinical research business of Thermo Fisher Scientific and Moderna, whose pioneering mRNA vaccine for COVID has been administered to hundreds of millions globally, were named ‘Clinical Research Team of the Year’ during the 2021 Citeline Awards.


See more of the latest Life Science news on and PharmiWeb.Jobs.

Editor Details

Related Links

Last Updated: 22-Apr-2022